200 Granville Street
Suite 2820
Vancouver, BC V6C 1S4
Canada
604 336 7906
https://www.aequuspharma.ca
Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 12
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Douglas Glen Janzen | Chairman, CEO & President | 140,83k | N/A | 1969 |
Ms. Ann Fehr CGA, CPA | CFO & Corporate Secretary | 92,95k | N/A | 1969 |
Mr. Grant Larsen | Chief Commercial Officer | 167k | N/A | N/A |
Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.
Aequus Pharmaceuticals Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.